| 31.54 0.29 (0.93%) | 04-22 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 39.32 | 1-year : | 41.49 |
| Resists | First : | 33.66 | Second : | 35.52 |
| Pivot price | 32.92  |
|||
| Supports | First : | 30.65 | Second : | 25.5 |
| MAs | MA(5) : | 31.85 |
MA(20) : | 33.44 |
| MA(100) : | 29.59 |
MA(250) : | 29.33 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 18.3 |
D(3) : | 23.2 |
| RSI | RSI(14): 37.7 |
|||
| 52-week | High : | 35.52 | Low : | 21.38 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ OPCH ] has closed above bottom band by 21.3%. Bollinger Bands are 33.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 32.01 - 32.19 | 32.19 - 32.33 |
| Low: | 30.24 - 30.46 | 30.46 - 30.64 |
| Close: | 30.92 - 31.25 | 31.25 - 31.53 |
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Tue, 22 Apr 2025
Elevance Health's Q1 Earnings Beat Estimates on Rising Premiums - TradingView
Tue, 22 Apr 2025
Best Growth Stocks to Buy for April 22nd - TradingView
Tue, 22 Apr 2025
Best Growth Stocks to Buy for April 22nd - Yahoo
Tue, 22 Apr 2025
Bridgewater Associates LP Sells 8,181 Shares of Option Care Health, Inc. (NASDAQ:OPCH) - MarketBeat
Mon, 21 Apr 2025
Bank of Nova Scotia Takes Position in Option Care Health, Inc. (NASDAQ:OPCH) - MarketBeat
Mon, 21 Apr 2025
Option Care Health, Inc. (NASDAQ:OPCH) Shares Bought by Marshall Wace LLP - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 164 (M) |
| Shares Float | 164 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 101.5 (%) |
| Shares Short | 4,080 (K) |
| Shares Short P.Month | 3,910 (K) |
| EPS | 1.23 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.44 |
| Profit Margin | 4.2 % |
| Operating Margin | 6.4 % |
| Return on Assets (ttm) | 6 % |
| Return on Equity (ttm) | 14.9 % |
| Qtrly Rev. Growth | 19.7 % |
| Gross Profit (p.s.) | 6.14 |
| Sales Per Share | 30.44 |
| EBITDA (p.s.) | 2.34 |
| Qtrly Earnings Growth | 11.6 % |
| Operating Cash Flow | 323 (M) |
| Levered Free Cash Flow | 235 (M) |
| PE Ratio | 25.61 |
| PEG Ratio | 0 |
| Price to Book value | 3.72 |
| Price to Sales | 1.03 |
| Price to Cash Flow | 16 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|